Answers are grounded in this paper and cite their sources.
Patients with rheumatoid arthritis in China have similar prevalence of comorbidities with other Asian countries. Advanced age and long disease duration are possible risk factors for comorbidities. On the contrary, MTX may protect RA patients from several major comorbidities, supporting its central role in the management of rheumatoid arthritis.
No takes yet. Share an insight, caveat, or question.
Co-authors et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: